Stephen Saklad

Clinical Professor, Director of Psychiatric Pharmacy

University of Texas at Austin

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stephen Saklad is a Clinical Professor and the Director of Psychiatric Pharmacy at The University of Texas at Austin. His research focuses on treatment patterns and outcomes in schizophrenia, particularly in relation to long-acting injectable antipsychotics and telepsychiatry. He has published several articles addressing pharmacokinetic characteristics, clinical management changes during the COVID-19 pandemic, and the optimization of antipsychotic treatment outcomes in inpatient settings.

Articles (6)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (1)

Srihari Gopal

Global Program Head

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephen Saklad

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Correction: Pharmacokinetic Characteristics of Long‑Acting Injectable Antipsychotics for Schizophrenia: An Overview

Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia

Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Collaborators (1)

Srihari Gopal

Make your next move.